Monday, November 5, 2018

Youngevity International, Inc. (NASDAQ: YGYI) CEO to Speak at the Cannabidiol Symposium

  • Youngevity CEO invited as a featured speaker to the Cannabidiol Symposium slated for November 6, 2018
  • Direct selling companies dealing with cannabidiol-related products projected to rake in up to $300 million in revenue
  • Youngevity adds phytocannabinoid-rich, full-spectrum HempFX into its line of products
Youngevity International, Inc. (NASDAQ: YGYI) is one of the leading direct selling companies for lifestyle products. The company has one of the most unique direct selling business models, combining the power of social selling and e-commerce. Among the categories in which its products are listed are home and family, health and nutrition, spa and beauty, food and beverage, essential oils, fashion, photo and innovative services.
On October 24, 2018, the company made an official announcement that it is participating in the Cannabidiol Symposium to be hosted by Direct Selling News and Success Partners. Among the featured speakers at the event scheduled for November 6, 2018, in Dallas, Texas, is the company’s CEO, Steve Wallach (http://ibn.fm/m31rb).
The opportunities in the direct selling market are enormous. In the case of cannabidiol-related products, projections suggest 2018 sales of over $300 million for companies in this niche. This effectively makes direct selling the largest and most preferred distribution channel for products in this sector.
Youngevity has made a strategic footprint by bringing together a variety of products and services under the same fold through a combined power of social selling and e-commerce. Official sources from the company express a strong belief that it is well positioned to leverage the cannabidiol direct selling boom to strengthen its foothold.
The CEO is optimistic that the event presents a unique opportunity where players in the industry will share information on the best practices in direct selling business models. Cannabidiol is one of the transformative products that is gaining traction in many jurisdictions around the world. Direct selling is the platform that will take this product to the consumers.
Youngevity has transitioned successfully to an international marketer of health and lifestyle products and services. According to the CEO, the invitation to speak at the symposium represents a recognition of the role and influence of the company in the direct selling channel and cannabidiol space.
HempFX is the latest product launched by Youngevity. It is a hemp-derived cannabidiol oil, rich in phytocannabinoid, that nurtures the body and complements health regimes. It is available in three proprietary formulas – Uplift, Relax and Soothe – all of which are double tested and contain no tetrahydrocannabinol.
The HempFX product line contains two tablet-based products designed to be used alongside Youngevity’s Y-DR8+ portable water system. This provides users with palatable water while reducing chemical traces found in piped water. The Y-DR8+ has an activated carbon cloth filter that is portable and convenient for today’s on-the-go lifestyle.
Youngevity was formed in 2011 following a merger between Javalution Coffee Company and Youngevity Essential Life Sciences. The company recorded annual revenues of $166 million in 2017, derived from both direct selling and its coffee industry business segment.
For more information, visit the company’s website at www.YGYI.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html